Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Burkholderia ambifaria Probable intracellular septation protein A (BamMC406_1828), partial CSB-YP459902BXP1
CSB-EP459902BXP1
CSB-BP459902BXP1
CSB-MP459902BXP1
CSB-EP459902BXP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia ambifaria Ribonuclease HII (rnhB) CSB-YP459903BXP
CSB-EP459903BXP
CSB-BP459903BXP
CSB-MP459903BXP
CSB-EP459903BXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia ambifaria 30S ribosomal protein S2 (rpsB) CSB-YP459904BXP
CSB-EP459904BXP
CSB-BP459904BXP
CSB-MP459904BXP
CSB-EP459904BXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia ambifaria 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (dapD) CSB-YP459905BXP
CSB-EP459905BXP
CSB-BP459905BXP
CSB-MP459905BXP
CSB-EP459905BXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia ambifaria Phospho-N-acetylmuramoyl-pentapeptide-transferase (mraY), partial CSB-YP459906BXP
CSB-EP459906BXP
CSB-BP459906BXP
CSB-MP459906BXP
CSB-EP459906BXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia ambifaria 50S ribosomal protein L21 (rplU) CSB-YP459907BXP
CSB-EP459907BXP
CSB-BP459907BXP
CSB-MP459907BXP
CSB-EP459907BXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia ambifaria Dihydrodipicolinate reductase (dapB) CSB-YP459908BXP
CSB-EP459908BXP
CSB-BP459908BXP
CSB-MP459908BXP
CSB-EP459908BXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia ambifaria Imidazolonepropionase (hutI) CSB-YP459909BXP
CSB-EP459909BXP
CSB-BP459909BXP
CSB-MP459909BXP
CSB-EP459909BXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia ambifaria Holliday junction ATP-dependent DNA helicase RuvB (ruvB) CSB-YP459910BXP
CSB-EP459910BXP
CSB-BP459910BXP
CSB-MP459910BXP
CSB-EP459910BXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia ambifaria Probable inorganic polyphosphate/ATP-NAD kinase (ppnK) CSB-YP459911BXP
CSB-EP459911BXP
CSB-BP459911BXP
CSB-MP459911BXP
CSB-EP459911BXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia ambifaria NADH-quinone oxidoreductase subunit D (nuoD) CSB-YP459912BXP
CSB-EP459912BXP
CSB-BP459912BXP
CSB-MP459912BXP
CSB-EP459912BXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia ambifaria 2-isopropylmalate synthase (leuA), partial CSB-YP459913BXP
CSB-EP459913BXP
CSB-BP459913BXP
CSB-MP459913BXP
CSB-EP459913BXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia ambifaria Homogentisate 1,2-dioxygenase (hmgA) CSB-YP459914BXP
CSB-EP459914BXP
CSB-BP459914BXP
CSB-MP459914BXP
CSB-EP459914BXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia ambifaria Ribosomal RNA large subunit methyltransferase H (rlmH) CSB-YP459915BXP
CSB-EP459915BXP
CSB-BP459915BXP
CSB-MP459915BXP
CSB-EP459915BXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia ambifaria N utilization substance protein B homolog (nusB) CSB-YP459916BXP
CSB-EP459916BXP
CSB-BP459916BXP
CSB-MP459916BXP
CSB-EP459916BXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia ambifaria Methionine--tRNA ligase (metG), partial CSB-YP459917BXP
CSB-EP459917BXP
CSB-BP459917BXP
CSB-MP459917BXP
CSB-EP459917BXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia ambifaria Fructose-1,6-bisphosphatase class 1 (fbp) CSB-YP459918BXP
CSB-EP459918BXP
CSB-BP459918BXP
CSB-MP459918BXP
CSB-EP459918BXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia ambifaria 30S ribosomal protein S16 (rpsP) CSB-YP459919BXP
CSB-EP459919BXP
CSB-BP459919BXP
CSB-MP459919BXP
CSB-EP459919BXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia ambifaria Quinolinate synthase A (nadA) CSB-YP459920BXP
CSB-EP459920BXP
CSB-BP459920BXP
CSB-MP459920BXP
CSB-EP459920BXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia ambifaria Adenylate kinase (adk) CSB-YP459921BXP
CSB-EP459921BXP
CSB-BP459921BXP
CSB-MP459921BXP
CSB-EP459921BXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>